---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-003114"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:31:11.635522+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab regains Nasdaq minimum bid price compliance, avoids delisting

## Summary
- Received Nasdaq Panel confirmation on Apr 30, 2025, that BGLC met $1.00 minimum bid price rule.
- Stock closed at $1.00+ for required consecutive business days as of Apr 23, 2025.
- Company plans to expand RNA diagnostics and specialty chemicals via Chemrex and MRNA Scientific.
- Appointed new independent board members and formed internal audit function to strengthen governance.

## SEC filing metadata
- accession: 0001477932-25-003114
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225003114/0001477932-25-003114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225003114/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-003114
- JSON: https://secwatch.observer/filing/0001477932-25-003114.json
- Plain text: https://secwatch.observer/filing/0001477932-25-003114.txt

## Key facts
- Listing & Compliance Notices
  BioNexus Gene Lab Corp received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 30, 2025, BioNexus Gene Lab Corp. (the “Company”) received a formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. The Company was previously notified of non-compliance with the Bid Price Rule and appeared before the Panel pursuant to Docket No. NQ 7050C-24. As of April 23, 2025, the Company’s common stock had maintained a closing bid price of $1.00 or greater for the requisite number of consecutive business day
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793225003114/0001477932-25-003114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.